Compare XBIT & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | DIT |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 64.4M |
| IPO Year | 2015 | 1996 |
| Metric | XBIT | DIT |
|---|---|---|
| Price | $1.88 | $62.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.8K | 1.5K |
| Earning Date | 11-20-2026 | 08-05-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $1,392,388,157.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.47 | N/A |
| P/E Ratio | ★ N/A | $43.50 |
| Revenue Growth | N/A | ★ 5.30 |
| 52 Week Low | $1.80 | $59.15 |
| 52 Week High | $3.44 | $118.50 |
| Indicator | XBIT | DIT |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 47.59 |
| Support Level | $1.80 | $59.58 |
| Resistance Level | $2.42 | $65.04 |
| Average True Range (ATR) | 0.12 | 2.07 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 27.27 | 27.50 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.